Sex differences in sleep apnea and comorbid neurodegenerative diseases

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Sleep apnea is a disorder, which increasingly affects people worldwide. Whether the associated hypoxic events during sleep are central or obstructive in origin, the end result is excessive daytime sleepiness and an increased risk for several comorbidities, such as cardiovascular and neurodegenerative disorders. Sleep apnea is diagnosed more frequently in men than women, suggesting a role of sex hormones in the pathology of the disease. Furthermore, there are sex differences in the development and progression of comorbid diseases associated with sleep apnea. Therefore, treatment of sleep apnea may be clinically relevant for prevention of subsequent sex-specific comorbid disorders. While the impact sleep apnea has on cardiovascular events has been the subject of many research studies, the role of sleep apnea in neurodegeneration is less established. Here we review known risk factors for sleep apnea and the implications of the observed sex differences in this disease. We also summarize the evidence and mechanisms for how sleep apnea may contribute to the onset of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

Original languageEnglish
Pages (from-to)28-33
Number of pages6
JournalSteroids
Volume133
DOIs
StatePublished - 1 May 2018

Fingerprint

Neurodegenerative diseases
Sleep Apnea Syndromes
Sex Characteristics
Neurodegenerative Diseases
Sleep
Gonadal Steroid Hormones
Pathology
Parkinson Disease
Disease Progression
Comorbidity
Alzheimer Disease

Keywords

  • Androgens
  • Chronic intermittent hypoxia
  • Estrogens
  • Hypertension
  • Inflammation
  • Oxidative stress

Cite this

@article{bb54719eca5e4b48a0ee8f72f4f66530,
title = "Sex differences in sleep apnea and comorbid neurodegenerative diseases",
abstract = "Sleep apnea is a disorder, which increasingly affects people worldwide. Whether the associated hypoxic events during sleep are central or obstructive in origin, the end result is excessive daytime sleepiness and an increased risk for several comorbidities, such as cardiovascular and neurodegenerative disorders. Sleep apnea is diagnosed more frequently in men than women, suggesting a role of sex hormones in the pathology of the disease. Furthermore, there are sex differences in the development and progression of comorbid diseases associated with sleep apnea. Therefore, treatment of sleep apnea may be clinically relevant for prevention of subsequent sex-specific comorbid disorders. While the impact sleep apnea has on cardiovascular events has been the subject of many research studies, the role of sleep apnea in neurodegeneration is less established. Here we review known risk factors for sleep apnea and the implications of the observed sex differences in this disease. We also summarize the evidence and mechanisms for how sleep apnea may contribute to the onset of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.",
keywords = "Androgens, Chronic intermittent hypoxia, Estrogens, Hypertension, Inflammation, Oxidative stress",
author = "Brina Snyder and Cunningham, {Rebecca Lynn}",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.steroids.2017.12.006",
language = "English",
volume = "133",
pages = "28--33",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",

}

Sex differences in sleep apnea and comorbid neurodegenerative diseases. / Snyder, Brina; Cunningham, Rebecca Lynn.

In: Steroids, Vol. 133, 01.05.2018, p. 28-33.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sex differences in sleep apnea and comorbid neurodegenerative diseases

AU - Snyder, Brina

AU - Cunningham, Rebecca Lynn

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Sleep apnea is a disorder, which increasingly affects people worldwide. Whether the associated hypoxic events during sleep are central or obstructive in origin, the end result is excessive daytime sleepiness and an increased risk for several comorbidities, such as cardiovascular and neurodegenerative disorders. Sleep apnea is diagnosed more frequently in men than women, suggesting a role of sex hormones in the pathology of the disease. Furthermore, there are sex differences in the development and progression of comorbid diseases associated with sleep apnea. Therefore, treatment of sleep apnea may be clinically relevant for prevention of subsequent sex-specific comorbid disorders. While the impact sleep apnea has on cardiovascular events has been the subject of many research studies, the role of sleep apnea in neurodegeneration is less established. Here we review known risk factors for sleep apnea and the implications of the observed sex differences in this disease. We also summarize the evidence and mechanisms for how sleep apnea may contribute to the onset of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

AB - Sleep apnea is a disorder, which increasingly affects people worldwide. Whether the associated hypoxic events during sleep are central or obstructive in origin, the end result is excessive daytime sleepiness and an increased risk for several comorbidities, such as cardiovascular and neurodegenerative disorders. Sleep apnea is diagnosed more frequently in men than women, suggesting a role of sex hormones in the pathology of the disease. Furthermore, there are sex differences in the development and progression of comorbid diseases associated with sleep apnea. Therefore, treatment of sleep apnea may be clinically relevant for prevention of subsequent sex-specific comorbid disorders. While the impact sleep apnea has on cardiovascular events has been the subject of many research studies, the role of sleep apnea in neurodegeneration is less established. Here we review known risk factors for sleep apnea and the implications of the observed sex differences in this disease. We also summarize the evidence and mechanisms for how sleep apnea may contribute to the onset of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

KW - Androgens

KW - Chronic intermittent hypoxia

KW - Estrogens

KW - Hypertension

KW - Inflammation

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=85039149938&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2017.12.006

DO - 10.1016/j.steroids.2017.12.006

M3 - Article

C2 - 29258810

AN - SCOPUS:85039149938

VL - 133

SP - 28

EP - 33

JO - Steroids

JF - Steroids

SN - 0039-128X

ER -